4//SEC Filing
MANCHESTER KEITH S 4
Accession 0001447028-24-000078
CIK 0001447028other
Filed
Aug 15, 8:00 PM ET
Accepted
Aug 16, 4:07 PM ET
Size
333.3 KB
Accession
0001447028-24-000078
Insider Transaction Report
Form 4
MANCHESTER KEITH S
Director
Transactions
- Exercise/Conversion
Common Shares
2024-08-14$0.56/sh+54,915$30,752→ 54,915 total - Sale
Common Shares
2024-08-14$3.69/sh−8,846$32,637→ 46,069 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-08-14−54,915→ 0 totalExercise: $0.56Exp: 2024-11-13→ Common Shares (54,915 underlying)
Footnotes (2)
- [F1]Cashless exercise and hold transaction in director stock options due to expire on November 13, 2024, ten years after such options were granted, including the sale of 8,846 of the underlying shares to pay the exercise price. None of the net 46,069 shares were sold.
- [F2]This is a director stock option grant that is fully vested.
Issuer
Arbutus Biopharma Corp
CIK 0001447028
Entity typeother
Related Parties
1- filerCIK 0001244828
Filing Metadata
- Form type
- 4
- Filed
- Aug 15, 8:00 PM ET
- Accepted
- Aug 16, 4:07 PM ET
- Size
- 333.3 KB